Colorectal Cancer Market to Reach US$ 22,953.8 Mn at a CAGR of 4.0% in 2027 | The Insight Partners
Medical Device Colorectal Cancer Market to 2027- G...

Colorectal Cancer Market to 2027- Global Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Geography

Publication Month: Nov 2019 | Report Code: TIPRE00006881 | No. of Pages: 229 | Category: Medical Device | Status: Published

The global Colorectal Cancer market is anticipated to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027.

 

The report provides trends prevailing in the global colorectal cancer market and the factors driving the market along with those that act as hindrances. The market for colorectal cancer is expected to grow, owing to factors such as increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.

 

Exhibit: Lucrative Regional Markets


 

Market Insights

New Product Launches

The market for colorectal cancer drugs is driven by frequent diagnostic tests and drug launches. Most of the major market players are involved in the manufacturing wide range of drugs and diagnostic tests that help in reducing the burden of colorectal cancer. For instance, in June 2019, Pfizer, Inc. launched ZIRABEV, a biosimilar to Avastin that helps in the treatment of five cancers, including colorectal cancer. Moreover, in September 2019, Lupin, an Indian pharmaceutical company, partnered with German-based Boehringer Ingelheim pharmaceutical company for the development of cancer drugs. The companies came together to develop and commercialize a drug based on the MEK inhibitor. This molecule is likely to target specific cancer cells and treat patients suffering from stomach and skin cancer.

Furthermore, the companies are also focused on the development of new diagnostic tests that will help in the accurate detection of colorectal cancer. For instance, in December 2016, Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, introduced Colvera, a blood-based diagnostic test for colorectal cancer recurrence monitoring.

Thus, the constant developments in colorectal cancer diagnostics and therapeutics are expected to accelerate the market growth during the forecast period.

 

Growing Pharmaceutical Industry In Emerging Economies

The rising pharmaceutical industry in the developing countries in the Asia Pacific region are creating better opportunities for significant market players to expand their business. This is a substantial reason for growth of the market in the forecast period. According to statistics India Brand Equity Foundation (IBEF) in April 2019, India is the largest provider of generic drugs worldwide. The Indian pharmaceutical industry supplies approximately 40% of generic demand in the US, with around 50% of world demand for multiple vaccines and 25 % of all medicines in the United Kingdom. The Indian pharmaceutical industrial sector was valued at US$ 33 billion in 2017 and is expected to expand at a CAGR of 22.4% over 2015–2020 to reach US$ 55 billion. In addition, India has a huge pool of scientists and engineers having the potential to grow the industry to an even higher level.

Thus, increasing medical tourism in emerging countries and growing pharmaceuticals in the region is expected to boost the market and is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

 

Product Insights

The global colorectal cancer market, based on modality, has been segmented into diagnosis type, therapy type, imaging type. The diagnosis type segment held the largest share of the market in 2018. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Exhibit: Colorectal cancer Market, by Type                

       

 

 

Strategic Insights

Growth strategies through several organic and inorganic such as approvals, product launch, agreements, and partnerships have been witnessed in the market of colorectal cancer. For instance, in October 2019, Novigenix announced that Helsana, the leading health insurance provider in Switzerland has approved offering coverage for reimbursement for the Colox, a liquid biopsy test for early detection of colorectal cancer.


Global Colorectal Cancer Market – By Type

  • Diagnosis Type
  • Therapy Type
  • Imaging Type

 

Global Colorectal Cancer Market – By End User

  • Hospitals
  • Diagnostic and Research Laboratories

 

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • Epigenomics AG
  • Novigenix SA
  • Clinical Genomics Technologies Pty Ltd.
  • EDP Biotech Corporation
  • Volitionrx Limited
  • Abbott Laboratories
  • Amgen Inc.
  • F. Hoffmann-La Roche AG
  • Bruker Corporation
  • Quest Diagnostics Incorporated
  • Natera, Inc.
  • Guardant Health

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Colorectal Cancer Market – By Modality

1.3.2        Global Colorectal Cancer Market – By End User

1.3.3        Global Colorectal Cancer Market – By Geography

2.             Colorectal Cancer Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Colorectal Cancer– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Colorectal Cancer Market - North America PEST Analysis

4.2.2        Colorectal Cancer Market - Europe PEST Analysis

4.2.3        Colorectal Cancer Market – Asia Pacific PEST Analysis

4.2.4        Colorectal Cancer Market – Middle East & Africa PEST Analysis

4.2.5        Colorectal Cancer Market – South And Central America PEST Analysis

4.3       Expert Opinion

4.4       Primary Care Physician And Practice Characteristics (US)

4.4.1        Practice Environment And Practice Patterns

4.4.2        US Census Region (Prevalence- 2018)

4.4.3        Typical Number Of Patients Per Week

4.4.4        CRC Screening Tests Ordered, Referred Or Performed Per Month

4.4.5        Number Of CRC Screening Modalities Recommended

4.5       Number Of Patients By Stage (US)

4.6       Number Of CEA Tests (US)

4.7       US Colorectal Cancer Prevalence- 2018

5.             Colorectal Cancer– Key Dynamics

5.1       Key Drivers

5.1.1        Increasing Prevalence Of Colorectal Cancer

5.1.2        New Product Launches

5.1.3        Benefits Offered By Generic Drugs

5.2       Key Restraints

5.2.1        Pricing Pressure On Drug Manufacturers

5.3       Key Market Opportunities

5.3.1        Growing Pharmaceutical Industry In Emerging Economies

5.4       Future Trends

5.4.1        Inclination Towards Personalized Medicine

5.5       Impact Analysis

6.             Colorectal Cancer Market – Global Analysis

6.1       Global Colorectal Cancer Market Revenue Forecasts And Analysis

6.2       Global Colorectal Cancer Market, By Geography - Forecasts And Analysis

6.3       Positioning Of Key Players

7.             Colorectal Cancer Market Analysis And Forecasts To 2027 – Modality

7.1       Overview

7.2       Global Colorectal Cancer Market, By Modality 2018 & 2027 (%)

7.3       Diagnosis Type Market

7.3.1        Overview

7.3.2        Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Immunohistochemistry Market

7.3.3.1      Overview

7.3.3.2      Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4        Stool Test Market

7.3.4.1      Overview

7.3.4.2      Stool Test Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5        Flexible Sigmoidoscopy Market

7.3.5.1      Overview

7.3.5.2      Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)

7.3.6        Colonoscopy Market

7.3.6.1      Overview

7.3.6.2      Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)

7.3.7        CEA Test Market

7.3.7.1      Overview

7.3.7.2      CEA Test Market Revenue and Forecast to 2027 (US$ Mn)

7.3.8        Other Test Market

7.3.8.1      Overview

7.3.8.2      Other Test Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Therapy Type Market

7.4.1        Overview

7.4.2        Global Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        Chemotherapy Market

7.4.3.1      Overview

7.4.3.2      Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.3      Alkylating Agent Market

7.4.3.3.1       Overview

7.4.3.3.2       Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.4      Antimetabolites Market

7.4.3.4.1       Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.5      Others Market

7.4.3.5.1       Others Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Immunotherapy Market

7.4.4.1      Overview

7.4.4.2      Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.3      Panitumumab Market

7.4.4.3.1       Overview

7.4.4.3.2       Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.4      Cetuximab Market

7.4.4.4.1       Overview

7.4.4.4.2       Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.5      Bevacizumab Market

7.4.4.5.1       Overview

7.4.4.5.2       Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.6      Others Market

7.4.4.6.1       Overview

7.4.4.6.2       Others Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5        Chemoprotectant Market

7.4.5.1      Overview

7.4.5.2      Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)

7.4.6        Others Market

7.4.6.1      Overview

7.4.6.2      Others Market Revenue and Forecast to 2027 (US$ Mn)

7.5       Imaging Type Market

7.5.1        Overview

7.5.2        Global Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)

7.5.3        Computed Tomography (CT) Market

7.5.3.1      Overview

7.5.3.2      Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4        Magnetic Resonance Imaging (MRI) Market

7.5.4.1      Overview

7.5.4.2      Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)

7.5.5        Others Market

7.5.5.1      Overview

7.5.5.2      Others Market Revenue and Forecast to 2027 (US$ Mn)

8.             Global Colorectal Cancer Market Analysis– By End User

8.1       Overview

8.2       Global Colorectal Cancer Market, By End User 2018 & 2027 (%)

8.3       Hospitals Market

8.3.1        Overview

8.3.2        Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Diagnostic and Research Laboratories Market

8.4.1        Overview

8.4.2        Global Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Colorectal Cancer Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1       North America Colorectal Cancer Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3        North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.3.1      North America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2      North America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2.1       North America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2.2       North America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.3      North America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4        North America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.5        North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)

9.1.6        US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1      US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2      US Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.6.2.1       US Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2       US Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2.1           US Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2.2           US Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.3       US Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.3      US Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.7        Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1      Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2      Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.7.2.1       Canada Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2       Canada Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2.1           Canada Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2.2           Canada Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.3       Canada Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.3      Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.8        Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1      Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2      Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.8.2.1       Mexico Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2       Mexico Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2.1           Mexico Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2.2           Mexico Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.3       Mexico Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.3      Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.2       Europe Colorectal Cancer Market Revenue and Forecasts To 2027

9.2.1        Overview

9.2.2        Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.2.3.1      Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.3.2      Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.3.2.1       Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)